LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

10X Genomics Inc (Class A)

Suletud

SektorTervishoid

11.04 6.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.17

Max

11.17

Põhinäitajad

By Trading Economics

Sissetulek

15M

-34M

Müük

-10M

155M

Aktsiakasum

-0.102

Kasumimarginaal

-22.183

Töötajad

1,306

EBITDA

-1.5M

-39M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+24.76% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

100M

1.2B

Eelmine avamishind

4.78

Eelmine sulgemishind

11.04

Uudiste sentiment

By Acuity

34%

66%

99 / 381 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

10X Genomics Inc (Class A) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. juuni 2025, 22:33 UTC

Omandamised, ülevõtmised, äriostud

KKR to Acquire Australian Power Provider Zenith Energy

16. juuni 2025, 21:55 UTC

Suurimad hinnamuutused turgudel

Geospace Technologies Shares Up on Petrobras Pact

16. juuni 2025, 17:04 UTC

Suurimad hinnamuutused turgudel

Roku Shares Climb on Advertising Deal with Amazon

16. juuni 2025, 23:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. juuni 2025, 23:51 UTC

Market Talk

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

16. juuni 2025, 23:41 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

16. juuni 2025, 23:10 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

16. juuni 2025, 23:02 UTC

Market Talk

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

16. juuni 2025, 22:32 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

16. juuni 2025, 22:03 UTC

Omandamised, ülevõtmised, äriostud

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

16. juuni 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

16. juuni 2025, 21:56 UTC

Tulu

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

16. juuni 2025, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

16. juuni 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16. juuni 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. juuni 2025, 20:49 UTC

Market Talk

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

16. juuni 2025, 20:14 UTC

Omandamised, ülevõtmised, äriostud

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

16. juuni 2025, 20:13 UTC

Market Talk

Natural Gas Gains on Warmer Outlook -- Market Talk

16. juuni 2025, 19:58 UTC

Omandamised, ülevõtmised, äriostud

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

16. juuni 2025, 19:13 UTC

Market Talk

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

16. juuni 2025, 19:09 UTC

Market Talk

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

16. juuni 2025, 18:43 UTC

Market Talk

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

16. juuni 2025, 18:36 UTC

Market Talk

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

16. juuni 2025, 18:29 UTC

Market Talk

Global Equities Roundup: Market Talk

16. juuni 2025, 18:29 UTC

Market Talk

Shopify Appears More Resilient Than Feared -- Market Talk

16. juuni 2025, 18:22 UTC

Market Talk

Citi Forecasts Downturn in Gold Futures -- Market Talk

16. juuni 2025, 16:42 UTC

Market Talk

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

16. juuni 2025, 16:37 UTC

Market Talk

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

16. juuni 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

10X Genomics Inc (Class A) Prognoos

Hinnasiht

By TipRanks

24.76% tõus

12 kuu keskmine prognoos

Keskmine 13 USD  24.76%

Kõrge 18 USD

Madal 9 USD

Põhineb 10 Wall Streeti analüütiku instrumendi 10X Genomics Inc (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

4

Osta

6

Hoia

0

Müü

Tehniline skoor

By Trading Central

8.32 / 8.63Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

No Evidence

Sentiment

By Acuity

99 / 381 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.